Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongchao He

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Cell & Bioscience|September 10, 2023
The SIRT7-mediated deacetylation of CHD1L amplifies HIF-2α-dependent signal that drives renal cell carcinoma progression and sunitinib resistanceHongchao He, Jie Li, Wei Wang, et al.
Aging|November 21, 2019
Development and validation of a metastasis-associated prognostic signature based on single-cell RNA-seq in clear cell renal cell carcinomaChuanjie Zhang, Hongchao He, Xin Hu, et al.
Journal of Cellular Physiology|July 4, 2018
Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signalingHongchao He, Jun Dai, Ran Zhuo, et al.
Journal of Surgical Oncology|January 31, 2019
Retrospective analysis of variant venous anatomy in 303 laparoscopic adrenalectomies and its clinical implicationsFukang Sun, Ran Zhuo, Wenming Ma, et al.
International Urology and Nephrology|March 27, 2017
Segmental ureterectomy is not inferior to radical nephroureterectomy for either middle or distal ureter urothelial cell carcinomas within 3.5 cmChen Fang, Xin Xie, Tianyuan Xu, et al.
Journal of Cellular and Molecular Medicine|March 19, 2025
DDR1 Targeting HOXA6 Facilitates Bladder Cancer Progression via Inhibiting FerroptosisXin Xie, Hongchao He, Ning Zhang, et al.
Theranostics|March 5, 2021
Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinomaChuanjie Zhang, Li Chen, Yihan Liu, et al.
Urologic Oncology|June 5, 2012
Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrenceJuping Zhao, Yu Zhu, Chongyu Zhang, et al.
Cancer Research|January 4, 2023
YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell CarcinomaJuan Jin, Fen Chen, Wenfang He, et al.
Translational Oncology|May 14, 2024
Deubiquitinase UCHL1 stabilizes KDM4B to augment VEGF signaling and confer bevacizumab resistance in clear cell renal cell carcinomaJie Cheng, Hanqing Liu, Yan Shen, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Cell & Bioscience|September 10, 2023
The SIRT7-mediated deacetylation of CHD1L amplifies HIF-2α-dependent signal that drives renal cell carcinoma progression and sunitinib resistanceHongchao He, Jie Li, Wei Wang, et al.
Aging|November 21, 2019
Development and validation of a metastasis-associated prognostic signature based on single-cell RNA-seq in clear cell renal cell carcinomaChuanjie Zhang, Hongchao He, Xin Hu, et al.
Journal of Cellular Physiology|July 4, 2018
Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signalingHongchao He, Jun Dai, Ran Zhuo, et al.
Journal of Surgical Oncology|January 31, 2019
Retrospective analysis of variant venous anatomy in 303 laparoscopic adrenalectomies and its clinical implicationsFukang Sun, Ran Zhuo, Wenming Ma, et al.
International Urology and Nephrology|March 27, 2017
Segmental ureterectomy is not inferior to radical nephroureterectomy for either middle or distal ureter urothelial cell carcinomas within 3.5 cmChen Fang, Xin Xie, Tianyuan Xu, et al.
Journal of Cellular and Molecular Medicine|March 19, 2025
DDR1 Targeting HOXA6 Facilitates Bladder Cancer Progression via Inhibiting FerroptosisXin Xie, Hongchao He, Ning Zhang, et al.
Theranostics|March 5, 2021
Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinomaChuanjie Zhang, Li Chen, Yihan Liu, et al.
Urologic Oncology|June 5, 2012
Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrenceJuping Zhao, Yu Zhu, Chongyu Zhang, et al.
Cancer Research|January 4, 2023
YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell CarcinomaJuan Jin, Fen Chen, Wenfang He, et al.
Translational Oncology|May 14, 2024
Deubiquitinase UCHL1 stabilizes KDM4B to augment VEGF signaling and confer bevacizumab resistance in clear cell renal cell carcinomaJie Cheng, Hanqing Liu, Yan Shen, et al.
Pageof 5